Stay updated on Nivolumab After SIRT for HCC Clinical Trial
Sign up to get notified when there's something new on the Nivolumab After SIRT for HCC Clinical Trial page.

Latest updates to the Nivolumab After SIRT for HCC Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedRevision: v3.5.4 is now shown on the page, replacing the previous Revision: v3.5.3. This reflects a site-wide interface update rather than a change to the study information.SummaryDifference0.1%

- Check20 days agoNo Change Detected
- Check27 days agoNo Change Detected
- Check34 days agoChange DetectedThe page’s footer/site revision indicator was updated from v3.5.2 to v3.5.3, reflecting a maintenance or release change without modifying the study details.SummaryDifference0.1%

- Check41 days agoChange DetectedAdded Revision: v3.5.2; Deleted Revision: v3.5.0.SummaryDifference0.1%

- Check70 days agoChange DetectedAdded Hepatocellular carcinoma to the site taxonomy and introduced a new Resources entry for the Genetic and Rare Diseases Information Center. Updated the revision from v3.4.3 to v3.5.0.SummaryDifference0.2%

- Check77 days agoChange DetectedSite revision updated to v3.4.3, replacing v3.4.2.SummaryDifference0.1%

- Check105 days agoChange DetectedRevision: v3.4.2 was added and the previous funding-status notice v3.4.1 was removed. The study details and page content remain unchanged; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to Nivolumab After SIRT for HCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab After SIRT for HCC Clinical Trial page.